Levofloxacin 250 mg + Ambroxol 75 mg SR Film-Coated Tablet

Levofloxacin 250 mg + Ambroxol 75 mg SR Film-Coated Tablet is a film-coated combination tablet formulated with Levofloxacin 250 mg + Ambroxol 75 mg SR. The active ingredient profile is Levofloxacin; Ambroxol, placing the product in the fluoroquinolone antibiotic + mucolytic combination category. Levofloxacin provides antibacterial activity, while Ambroxol is a mucolytic/expectorant ingredient used to reduce mucus viscosity and support airway clearance. The sustained-release designation indicates a modified-release presentation and must be described and used exactly according to the approved product literature. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad-spectrum claims. Clinical selection should depend on diagnosis, susceptibility or symptom profile, patient-specific factors and the prescriber's judgement. Prescription status, contraindications, precautions, interactions, adverse effects and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life and market-specific regulatory details should be added only from verified product documentation.